Skip to content
Trending
April 25, 2025German finance minister says trust not yet broken with U.S., prefers zero-for-zero tariff solution April 14, 2025Goldman Sachs tops estimates on boom in equities trading revenue April 22, 2025What the Discover merger approval means for Capital One and 2 other financials May 16, 2025Big Chinese companies like Alibaba show that AI-powered ads are giving shopping a boost February 6, 2025MicroStrategy unveils new name, reports accelerated bitcoin purchases in fourth quarter November 9, 2025‘We’re past peak-restrictiveness,’ BOE governor says, as bets rise on Christmas rate cut September 10, 2025‘We’re all kind of in shock.’ Oracle’s revenue projections leave analysts slack-jawed August 3, 2025We own Linde to deliver in tough times. It didn’t disappoint this quarter February 20, 2025Walmart is getting a bump from a surprising cohort: Wealthier shoppers June 13, 2025Airlines divert, cancel flights after Israel’s strike on Iran closes airspace in Middle East
  Thursday 8 October 2026
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
  Earnings  Wall Street analysts rush to Eli Lilly’s defense but investors aren’t listening yet
Earnings

Wall Street analysts rush to Eli Lilly’s defense but investors aren’t listening yet

AdminAdmin—August 8, 20250
More stories

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

May 1, 2025

We’re raising our Nvidia price target after a great quarter and rosy guidance

June 22, 2025

Palantir stock pops 8% after blowout quarter driven by AI, efficiency demand

August 5, 2025

Affirm stock surges 12% as CEO Levchin notes continued consumer strength

August 29, 2025

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Stocks advanced Friday as Wall Street looks to close out a winning week. The S & P 500 and Dow Jones Industrial Average were solidly higher. Meanwhile, the tech-heavy Nasdaq Composite is on track for another record closing high. Next week all eyes will be on a slew of U.S. economic data, most notably on the inflation front. The consumer price index is due out Tuesday morning and carries implications for the Federal Reserve’s next monetary policy move. If inflation has picked up significantly, that could force the market to reconsider its expectations for a cut at the Fed’s September meeting. 2. Wall Street analysts came to Eli Lilly’s defense Friday after the stock plunged 14% Thursday on disappointing late-stage trial data for its obesity pill, which also overshadowed its overall solid quarterly earnings report. “Yesterday was just a disaster of a day,” said Jeff Marks, the Club’s director of portfolio analysis. Morgan Stanley said the sell-off was “overdone.” Meanwhile, JPMorgan argued that the pullback in shares creates a “compelling entry point.” Despite the positive Wall Street chatter, Eli Lilly stock fell another 2.5% during Friday trading. There’s a lot of hesitation to get back into the stock right now. We feel the same way, which is why the Club downgraded to a 3 rating, meaning sell into strength, and lowered our price target to $800 from $1,000. The analyst community is “all getting really behind Eli Lilly, but the investors [are] not quite yet,” Marks added. 3. Meta Platforms has reportedly turned to alternative asset manager Blue Owl Capital and bond giant PIMCO to lead a $29 billion financial deal to help fund the company’s data center expansion. Bloomberg News first reported on the deal. We applaud Meta’s push further into AI. “It really just shows their commitment to AI,” Marks said. “They’re not afraid to really use a lot of their cash flow to support these efforts.” Shares of the social media giant are up slightly on Friday. (Jim Cramer’s Charitable Trust is long LLY, META. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.

Dodge unveils additions to 2026 muscle car lineup: ‘It’s about choice’
Trump’s ‘reciprocal’ tariffs come into effect, hitting dozens of U.S. trading partners
Related posts
  • Related posts
  • More from author
Earnings

Google cloud growth tops Microsoft and Amazon as all three beat estimates on AI demand

May 2, 20260
Earnings

Nike tops earnings estimates but shares fall as China sales plunge, tariffs hit profits

December 18, 20250
Earnings

Salesforce’s raised guidance lifts the stock but doesn’t change our rating

December 17, 20250
Load more
Read also
Earnings

Google cloud growth tops Microsoft and Amazon as all three beat estimates on AI demand

May 2, 20260
Finance

Visa says new AI shopping tool has helped customers with hundreds of transactions

December 18, 20250
Economy

Trust these numbers? Economists see a lot of flaws in delayed CPI report showing downward inflation

December 18, 20250
Earnings

Nike tops earnings estimates but shares fall as China sales plunge, tariffs hit profits

December 18, 20250
Business

American Airlines no longer lets basic economy flyers earn miles

December 18, 20250
Finance

Billionaire fund manager Ron Baron praises beaten-up financial stock whose new CEO he compares to Jamie Dimon

December 17, 20250
Load more
    © 2022, All Rights Reserved.
    • About Us
    • Advertise With Us
    • Contact Us
    • Disclaimer
    • Cookie Law
    • Privacy Policy
    • Terms & Conditions